Johnson & Johnson
JNJ · NYSE
12/29/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $345 | $397 | $462 | $450 |
| - Cash | $24 | $22 | $13 | $14 |
| + Debt | $38 | $29 | $40 | $34 |
| Enterprise Value | $359 | $405 | $488 | $469 |
| Revenue | $89 | $85 | $80 | $79 |
| % Growth | 4.3% | 6.5% | 1.6% | – |
| Gross Profit | $61 | $59 | $55 | $55 |
| % Margin | 69.1% | 68.8% | 69.3% | 70.3% |
| EBITDA | $25 | $23 | $27 | $27 |
| % Margin | 27.9% | 27.4% | 33.3% | 34% |
| Net Income | $14 | $35 | $18 | $21 |
| % Margin | 15.8% | 41.3% | 22.4% | 26.5% |
| EPS Diluted | 5.79 | 13.72 | 6.73 | 7.81 |
| % Growth | -57.8% | 103.9% | -13.8% | – |
| Operating Cash Flow | $24 | $23 | $21 | $23 |
| Capital Expenditures | -$4 | -$5 | -$4 | -$4 |
| Free Cash Flow | $20 | $18 | $17 | $20 |